BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33329939)

  • 21. Genetic mosaics reveal both cell-autonomous and cell-nonautonomous function of murine p27Kip1.
    Chien WM; Rabin S; Macias E; Miliani de Marval PL; Garrison K; Orthel J; Rodriguez-Puebla M; Fero ML
    Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4122-7. PubMed ID: 16537495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cancer-associated CDKN1B mutation induces p27 phosphorylation on a novel residue: a new mechanism for tumor suppressor loss-of-function.
    Bencivenga D; Stampone E; Aulitto A; Tramontano A; Barone C; Negri A; Roberti D; Perrotta S; Della Ragione F; Borriello A
    Mol Oncol; 2021 Apr; 15(4):915-941. PubMed ID: 33316141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term exposure to superantigen induces p27Kip1 and Bcl-2 expression in effector memory CD4+ T cells.
    Koyanagi M; Fukada K; Uchiyama T; Yagi J; Arimura Y
    Cell Immunol; 2007 Aug; 248(2):77-85. PubMed ID: 18001700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
    Guo Y; Sklar GN; Borkowski A; Kyprianou N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p27 Kip1 nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by glycogen synthase kinase-3 in human colon cancer cells.
    Wang Q; Zhou Y; Wang X; Evers BM
    Cell Death Differ; 2008 May; 15(5):908-19. PubMed ID: 18408738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rho/ROCK pathway inhibition by the CDK inhibitor p27(kip1) participates in the onset of macrophage 3D-mesenchymal migration.
    Gui P; Labrousse A; Van Goethem E; Besson A; Maridonneau-Parini I; Le Cabec V
    J Cell Sci; 2014 Sep; 127(Pt 18):4009-23. PubMed ID: 25015295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-Regulation of CK2α Leads toUp-Regulation of the Cyclin-Dependent Kinase Inhibitor p27
    Guerra B; Dembic M; Siddiqui MA; Dominguez I; Ceppi P; Andresen BS
    Cell Physiol Biochem; 2020 Nov; 54(6):1177-1198. PubMed ID: 33216476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cyclin-dependent kinase inhibitor p27 kip1 regulates radial stem cell quiescence and neurogenesis in the adult hippocampus.
    Andreu Z; Khan MA; González-Gómez P; Negueruela S; Hortigüela R; San Emeterio J; Ferrón SR; Martínez G; Vidal A; Fariñas I; Lie DC; Mira H
    Stem Cells; 2015 Jan; 33(1):219-29. PubMed ID: 25185890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cyclin-dependent kinase inhibitor p27kip1 is required for transplantation tolerance induced by costimulatory blockade.
    Rowell EA; Wang L; Hancock WW; Wells AD
    J Immunol; 2006 Oct; 177(8):5169-76. PubMed ID: 17015702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
    Gesbert F; Sellers WR; Signoretti S; Loda M; Griffin JD
    J Biol Chem; 2000 Dec; 275(50):39223-30. PubMed ID: 11010972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastoma.
    Koomoa DL; Geerts D; Lange I; Koster J; Pegg AE; Feith DJ; Bachmann AS
    Int J Oncol; 2013 Apr; 42(4):1219-28. PubMed ID: 23440295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of p27
    Berton S; Cusan M; Segatto I; Citron F; D'Andrea S; Benevol S; Avanzo M; Dall'Acqua A; Schiappacassi M; Bristow RG; Belletti B; Baldassarre G
    Sci Rep; 2017 Apr; 7(1):595. PubMed ID: 28377607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus expressing p27kip1 suppresses growth of established esophageal carcinoma xenografts.
    Zhang WG; Wu QM; Yu JP; Tong Q; Xie GJ; Wang XH; Li SB
    World J Gastroenterol; 2005 Nov; 11(42):6582-6. PubMed ID: 16425348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p27
    Bencivenga D; Caldarelli I; Stampone E; Mancini FP; Balestrieri ML; Della Ragione F; Borriello A
    Cancer Lett; 2017 Sep; 403():354-365. PubMed ID: 28687353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles for p21waf1/cip1 and p27kip1 during the adaptation response to massive intestinal resection.
    Stehr W; Bernal NP; Erwin CR; Bernabe KQ; Guo J; Warner BW
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G933-41. PubMed ID: 16322092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
    Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
    Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer.
    Kelly-Spratt KS; Philipp-Staheli J; Gurley KE; Hoon-Kim K; Knoblaugh S; Kemp CJ
    Oncogene; 2009 Oct; 28(41):3652-62. PubMed ID: 19648963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of p27Kip1 by Sox2 maintains quiescence of inner pillar cells in the murine auditory sensory epithelium.
    Liu Z; Walters BJ; Owen T; Brimble MA; Steigelman KA; Zhang L; Mellado Lagarde MM; Valentine MB; Yu Y; Cox BC; Zuo J
    J Neurosci; 2012 Aug; 32(31):10530-40. PubMed ID: 22855803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene delivery of cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro.
    Jiang D; Wang X; Liu X; Li F
    Breast Cancer; 2014 Sep; 21(5):614-23. PubMed ID: 23338153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.